Lupus

• 

  Publication Venue For

  • The association of lupus nephritis with adverse pregnancy outcomes among women with lupus in North America..  31:1401-1407. 2022
  • The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activity..  31:697-705. 2022
  • Principles of pediatric lupus nephritis in a prospective contemporary multi-center cohort..  30:1660-1670. 2021
  • The importance of pregnancy planning in lupus pregnancies..  30:741-751. 2021
  • Low health numeracy is associated with higher disease activity in systemic lupus erythematosus..  30:489-494. 2021
  • 16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends..  29:1571-1593. 2020
  • Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry..  961203320940776. 2020
  • Effect of aspirin response signature gene expression on preterm birth and preeclampsia among women with lupus: a pilot study..  28:1640-1647. 2019
  • Provider perceptions on the management of lupus during pregnancy: barriers to improved care..  28:86-93. 2019
  • Reasons for cesarean and medically indicated deliveries in pregnancies in women with systemic lupus erythematosus..  27:351-356. 2018
  • Perceived stress and reported cognitive symptoms among Georgia patients with systemic lupus erythematosus..  26:1064-1071. 2017
  • Gestational weight gain in women with systemic lupus erythematosus..  26:623-632. 2017
  • Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus..  26:646-649. 2017
  • Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa..  26:186-194. 2017
  • Breastfeeding in mothers with systemic lupus erythematosus..  25:973-979. 2016
  • Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus: a systematic literature review..  25:617-626. 2016
  • Elevated C-reactive protein and self-reported disease activity in systemic lupus erythematosus..  23:1460-1467. 2014
  • Polypoidal choroidal vasculopathy and systemic lupus erythematosus..  23:319-322. 2014
  • Kidney allograft survival of African American and Caucasian American recipients with lupus..  23:151-158. 2014
  • Differential immunoglobulin class-mediated responses to components of the U1 small nuclear ribonucleoprotein particle in systemic lupus erythematosus and mixed connective tissue disease..  22:1371-1381. 2013
  • Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations..  22:855-864. 2013
  • Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I..  22:702-711. 2013
  • The impact of cyclophosphamide on menstruation and pregnancy in women with rheumatologic disease..  22:81-86. 2013
  • Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease..  20:274-289. 2011
  • 'Criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010..  20:182-190. 2011
  • Antiphospholipid Syndrome Clinical Research Task Force report..  20:219-224. 2011
  • Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort..  19:1315-1325. 2010
  • Antibodies to DNA: infection or genetics?.  18:1176-1180. 2009